JLK Inc

JLK Inc is a medical artificial intelligence company headquartered in Santa Clara, CA, specializing in AI-driven diagnostic solutions for neurological and oncological conditions. The company develops MEDIHUB, a comprehensive AI-based platform suite that processes multiple imaging modalities—including CT, CTA, MRI, MRA, digital pathology, endoscopy, X-ray, and mammography—to support clinical decision-making across stroke management and cancer detection. The MEDIHUB Stroke platform addresses the complete care continuum from acute-phase intervention to chronic-phase prognostic prediction, with integrated mobile applications enabling rapid diagnosis and treatment planning. MEDIHUB also covers dementia assessment and brain aging analysis, plus detection and analysis of 12 cancer types including prostate, breast, gastric, and colorectal cancers. JLK positions its technology as a workflow optimization tool designed to reduce door-to-treatment time in stroke management and improve patient outcomes through early, accurate disease detection. The company targets hospital systems, imaging centers, and diagnostic facilities requiring AI-powered image analysis and clinical decision support. No specific FDA 510(k) clearances, ISO certifications, or regulatory credentials are mentioned on the website.